Treatment of type 2 diabetes mellitus

American Family Physician

Volumn 59, Issue 10, 1999, Pages 2835-2844

  Florence, Joe A ^a   Yeager, Bryan F ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE INHIBITOR; BIGUANIDE; METFORMIN; MIGLITOL; ORAL ANTIDIABETIC AGENT; REPAGLINIDE; SULFONYLUREA DERIVATIVE; TROGLITAZONE;

DIET THERAPY; EXERCISE; FOLLOW UP; HUMAN; INSULIN RESISTANCE; KINESIOTHERAPY; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; WEIGHT REDUCTION;

COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 2; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYPOGLYCEMIC AGENTS; MASS SCREENING; OFFICE VISITS; PATIENT EDUCATION; RISK FACTORS; TEACHING MATERIALS;

EID: 0033562521     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Diabetes statistics. Bethesda, Md.: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, NIDDK, 1995; NIH publication no. 96-3926.
2. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1998;21(suppl 1):S5-19.
3. Uusitupa MI, Niskanen LK, Siitonen O, Voutilainen E, Pyorala K. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 1993;36:1175-84.
4. Clark CM Jr. How should we respond to the worldwide diabetes epidemic? [Editorial] Diabetes Care 1998;21:475-6.
5. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-97.
6. Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL 3d, et al. Diabetic retinopathy. Diabetes Care 1998;21:143-56.
7. Screening for type 2 diabetes. Diabetes Care 1998; 21(Suppl 1):S20-2.
8. Tests of glycemia in diabetes. Diabetes Care 1998;21(suppl 1):S69-71.
9. Classification, diagnostic criteria, and screening of diabetes. In: National Diabetes Data Group. Diabetes in America. 2d ed. Bethesda, Md.: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1995; NIH publication no. 95-1468.
10. Consensus development conference on insulin resistance. Diabetes Care 1998;21:310-4.
11. Diabetes Prevention Program (DPP). Fact sheet: information for health care providers. National Institute of Diabetes and Digestive and Kidney Diseases, 1996.
12. National Diabetes Education Initiative. How important is insulin resistance? Issues in Type 2 Diabetes 1998;2(1):1-3.
13. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998;352:837-53.
14. Mooradian AD. Drug therapy of non-insulin-dependent diabetes mellitus in the elderly. Drugs 1996;51:931-41.
15. Scheen AJ. Drug treatment of non-insulin-dependent diabetes mellitus in the 1990s. Achievements and future developments. Drugs 1997;54: 355-68.
16. Melchior WR, Jaber LA. Metformin: an antihyperglycemic agent for treatment of type II diabetes. Ann Pharmacother 1996;30:158-64.
17. Campbell LK, White JR, Campbell RK. Acarbose: its role in the treatment of diabetes mellitus. Ann Pharmacother 1996;30:1255-62.
18. Sparano N, Seaton TL. Troglitazone in type II diabetes mellitus. Pharmacotherapy 1998;18:539-48.
19. Inzucchi SE, Maggs DG, Spollett GR, Page SL, Rife FS, Walton V, et al. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N Engl J Med 1998;338:867-72.
20. Standards of medical care for patients with diabetes mellitus. Diabetes Care 1998;21(suppl 1):S23-31.
21. Goldberg RB, Holvey SM, Schneider J. A dose-response study of glimepiride in patients with NIDDM who have previously received sulfonylurea agents. Diabetes Care 1996;19:849-56.
22. Risks and benefits of intensive management in non-insulin-dependent diabetes mellitus. The Fifth Regenstrief Conference. Ann Intern Med 1996;124 (1 pt 2):81-186.